Source: MarketScreener

Pace Labs: Pace Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

(marketscreener.com) Acquisition adds significant experience and expertise in the development of liquid, semi-solid, and oral solid dose products for pre-clinical and clinical use, allowing Pace to support a growing number of clients throughout the drug development process.MINNEAPOLIS, Oct. 11, 2021 -- Pace Analytical Life Sciences®, LLC, a subsidiary of Pace...https://www.marketscreener.com/news/latest/Pace-Life-Sciences-Acquires-Velesco-Pharmaceutical-Services-Expanding-Capabilities-in-Drug-Develop--36650969/?utm_medium=RSS&utm_content=20211011

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Eric Roman's photo - President & CEO of Pace

President & CEO

Eric Roman

CEO Approval Rating

95/100

Read more